Does This Accelerator's Follow-On Promise Actually Mean Anything?

The question founders ask (and the one they should ask)

"What does 1% cost me?" is the question almost every founder brings into accelerator negotiations. It's the wrong question, or at least an incomplete one, because equity isn't the price of the program. It's the price of a bundle, and follow-on capital is one of the biggest things that may or may not be in that bundle.

Here's the actual question: does this program reserve follow-on capital specifically for companies in my vertical, or is "we follow on with our best companies" doing all the work with nothing behind it?

That second phrase shows up in a lot of pitch decks and program FAQs. It sounds like a commitment. It's actually a description of a pattern, maybe, with no obligation attached. A biotech accelerator can follow on with three companies out of forty and technically mean that sentence. A fintech program can have zero dollars reserved and still say it, because it's not a promise, it's a maybe dressed up in the past tense.

Why equity percentage alone is the wrong comparison

An extra point of equity for a program with no real follow-on reserve in your vertical is a worse deal than a lower check with a credible Series A pipeline behind it. Say that out loud to yourself before you sign anything.

Founders fixate on the percentage because it's the number that's easiest to compare across programs, and comparing numbers feels like due diligence. But 7% with a vague follow-on gesture and 6% with a documented reserve for your vertical are not close. The second program is giving you something real at a cheaper price. The first is charging you equity for a sentence.

This is the same mistake we cover in Stop Negotiating Equity Points. Ask This Question Instead.: the equity number is only meaningful once you know what it's buying. Check size, mentorship, and follow-on capital are three separate line items in that bundle, and they don't trade against equity at the same rate.

What a real follow-on reserve looks like versus a marketing line

A real reserve has a mechanism. It might be a named fund that invests in the accelerator's portfolio companies at Series A, a stated percentage of fund capital set aside for follow-on, or a documented history of specific check sizes at specific rounds for companies in your vertical. You can point to it. You can ask the program to name the fund, name a round, name a dollar range.

A marketing line has none of that. It has adjectives. "Strong track record," "deep conviction," "we double down on winners." None of those are mechanisms. None of them survive the question "can you name three companies in my vertical you followed on with, and what did that check look like?"

If a program can't answer that question with specifics, the honest conclusion is that the follow-on promise is unverified, not that it's false. Those are different things, and the difference matters for how much equity you should be willing to pay for it.

The jargon that actually matters here: MFN, pro-rata, and the SAFE

Once you know whether follow-on money is real, the fine print on your SAFE starts to matter in a different way.

Pro-rata rights let the accelerator invest more at your next round to keep its ownership percentage from getting diluted. That's a right to participate, not a commitment of new capital. A program can have pro-rata rights baked into every SAFE it signs and still have no actual fund behind exercising them. Rights without capital are optionality for the accelerator, not a promise to you.

MFN (most favored nation) clauses protect the accelerator if you later raise on better terms than the SAFE they gave you: their terms adjust to match. MFN protects the accelerator's deal. It says nothing about whether they'll write a follow-on check at all. Don't mistake an MFN clause for a follow-on commitment; they're unrelated protections on the same piece of paper.

The SAFE terms matter most after you've answered the follow-on question, not before. A clean SAFE attached to a program with no real follow-on capital is still a clean SAFE. It's just not buying you what you might have assumed it was.

How to check this before you apply, not after

This is exactly the kind of claim that's easy for a program to overstate in a pitch deck and hard for a founder to verify from the outside. That's the whole reason Accelerator Atlas exists: we read primary program documents, not marketing copy, and we show the source and check-date for every figure in the directory. Of our 105 listed programs, 102 are verified against primary sources, and each one carries a confidence tier (Verified, Secondary, or Unverified) so you know exactly how much weight to put on any given number.

If a program's follow-on terms aren't documented anywhere we can verify, we show a blank. A blank is more honest than repeating an accelerator's own pitch language back to you as fact, which is what a lot of directories quietly do.

If you're also checking whether a program's vertical focus is real or just branding, the same skepticism applies: see The Vertical Umbrella Trap for how to tell whether a "biotech accelerator" actually backs your subsector, and Does a 'Fintech Accelerator' Actually Know Your Subsector? for the fintech version of the same question.

Why this matters more during the fall wave

Fall is a second major deadline season, and if you're currently comparing fintech, biotech, or climate programs against each other, this is the moment to check follow-on terms side-by-side, before you've committed equity and joined a cohort, not after demo day when you find out the capital was never really there. Nobody wants to discover a vague promise three months into a program when the only move left is learning it.

If you haven't already got a system for tracking which program's deadline falls when, the deadline tracker guide is worth a read before the fall crunch gets worse.

Compare check size, equity, and, where we've verified it, follow-on terms side by side at acceleratoratlas.com/compare before you apply. Not after.